TLL-018 (a JAK1/TYK2 agent) vs. Tofacitinib in RA Save
Dr. Peter Nash reporting on abstract LB0001 from EULAR 2023 in Milan, Italy.
By downloading this material, I acknowledge that it may be used only for personal use and personal education and that I will accredit RheumNow.com as the source and owner of this material. Commercial use or mass reproduction of this material without permission from RheumNow (info@rheumnow.com) is prohibited.
If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.